Flow cytometric evaluation of the effect of various doses of vindesine sulphate on mouse spermatogenesis

Reproductive Toxicology

Volumn 11, Issue 6, 1997, Pages 867-874

  Jagetia, Ganesh Chandra ^a   Jyothi, P ^a   Krishnamurthy, H ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Flow cytometry; Mice; Spermatocytes; Spermatogonia; Testis; Vindesine

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ALKALOID; VINCA ALKALOID; VINDESINE;

ANIMAL; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FLOW CYTOMETRY; GERM CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; ORGAN WEIGHT; PATHOLOGY; PHYSIOLOGY; SPERMATOGENESIS; SPERMATOGONIUM; SPERMATOZOON; TESTIS; TESTIS WEIGHT; TOXICITY TESTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; FLOW CYTOMETRY; MALE; MICE; ORGAN SIZE; SPERMATOGENESIS; SPERMATOZOA; TESTIS; VINDESINE;

EID: 0031282710     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(97)00070-1     Document Type: Article

References (38)

1. 1. Jordan MA, Thrower D, Wilson L. Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res. 1991;51:2212-22.
2. 2. Palmer CG, Livengood D, Warren AK, Simpson PJ, Johnson IS. The action of vincaleukoblastine on dividing cells in vitro. Exp Cell Res. 1960;20:198-202.
3. 3. Cutts JH. The effect of vincaleukoblastine on dividing cells in vivo. Cancer Res. 1961;21:168-72.
4. 4. Himes RH, Kersey RN, Heller-bettinger I, Samson FE. Action of Vinca alkaloids vincristine, vinblastine and desacetyl vinblastinamide on microtubules in vitro. Cancer Res. 1976;36:3798-802.
5. 5. Owellen RJ, Hartke CA, Dickerson RM, Hains FO. Inhibition of tubulin-microtubule polymerization by drugs of the vinca alkaloid class. Cancer Res. 1976;36:1499-502.
6. 6. Wilson L, Anderson K, Chin D. Nonstoichiometric poisoning of microtubule polymerization: a model for the mechanism of action of the vinca alkaloids, podophyllotoxin and colchicine. In: Cold Spring Harbor Conference Cell Proliferation. 1976;3:1051-64.
7. 7. Wilson L, Jordan MA, Morse A, Margolis RL. Interaction of vinblastine with steady-state microtubules in vitro. J Mol Biol. 1982;159:125-49.
8. 8. Weiss HD, Walker MD, Wiernik PH. Neurotoxicity of commonly used anti-neoplastic agents. N Engl J Med. 1974;291:75.
9. 9. Bernstam VA, Gray RH, Bernstein IA. Effect of microtubule disrupting drugs on protein and RNA synthesis in Physarum polycephalum amoebae. Arch Microbiol. 1980;128:34-40.
10. 10. Creasy WA. Modifications in biochemical pathways produced by the Vinca alkaloids. Cancer Chemother Res. 1968;52:501-7.
11. 11. Creasy WA. Biochemical effects of vindesine. Br J Cancer. 1981;44:921-4.
12. 12. Howard SMH, Theologides A, Sheppard JR. Comparative effects of vindesine, vinblastine and vincristine on mitotic arrest and hormonal response of L1210 leukemia cells. Cancer Res. 1980;40: 2695-700.
13. 13. Sheppard JR. Effects of Vinca alkaloids on cyclic AMP metabolism of mouse splenic lymphocytes. Contrib Oncol. 1980;6:27-36.
14. 14. Beck WT. Increase by vinblastine of oxidized glutathione in cultured mammalian cells. Biochem Pharmacol. 1980;29:2333-7.
15. 2+-transport ATPase. Contrib Oncol. 1980;6:16-26.
16. 16. Brade WP. Critical review of pharmacology, toxicology, pharmacokinetics of vincristine, vindesine, vinblastine. Contrib Oncol. 1980;6:95-123.
17. 17. Gerzon K. Dimeric Catharanthus alkaloids. In: Cassady JM, Douros JD, eds. Anticancer agents based on natural product models. New York: Academic Press; 1980;271-317.
18. 18. Lu CC, Meistrich ML. Cytotoxic effects of chemotherapeutic drugs on mouse testis cells. Cancer Res. 1979;39:3575-82.
19. 19. Hansen PV, Sörensen D. Effect of vincristine or bleomycin on radiation-induced cell killing of mice spermatogonial stem cells: the importance of sequence and time interval. Int J Radiat Oncol Biol Phys. 1991;20:339-41.
20. 20. Jagetia GC, Krishnamurthy H, Jyothi P. Evaluation of cytotoxic effects of different doses of vinblastine on mouse spermatogenesis by flow cytometry. Toxicology. 1996;110:227-36.
21. 21. Gralla RJ, Tan CJ, Young CW. Vindesine: A review of phase II trials. Cancer Chemother Pharmacol. 1979;2:271-4.
22. 22. Furuse K, Kamimori T, Kawahara M, et al. A pilot study of concurrent whole-brain radiotherapy and chemotherapy combined with cis-platin, vindesine and mitomycin in non-small cell lung cancer with brain metastasis. Br J Cancer. 1997;75:614-8.
23. 23. Hirose M, Ishimoto K, Ninomiya T, Kuroda Y. Treatment of patients with Langerhan's cell histiocytosis with vindesine (letter). J Pediatr Hematol Oncol. 1996;18:421-2.
24. 24. Jagetia GC, Jyothi P. Enhancement of micronuclei frequency by vindesine in mouse bone marrow. Mutat Res. 1997;388:1-5.
25. 25. Oakberg EF. Duration of spermatogenesis in the mouse and timing of stages of the cycle of the seminiferous epithelium. Am J Anat. 1956;99:507-16.
26. 26. Oakberg EF. Spermatogonial stem cell renewal in mouse. Anat Record. 1971;169:515-31.
27. 27. Meistrich ML, Hunter NR, Suzuki N, Trostk PK, Withers HR. Gradual regeneration of mouse testicular stem cells after exposure to ionizing radiation. Radiat Res. 1978;74:349-62.
28. 28. Evenson DP, Melamed MR. Rapid analysis of normal and abnormal cell types in human semen and testis biopsies by flow cytometry. J Histochem Cytochem. 1983;31:248-53.
29. 29. Suresh R, Aravindan GR, Moudgal NR. Quantitation of spermatogenesis by DNA flow cytometry: Comparative study among six species of mammals. J Biosci. 1992;17:413-9.
30. 30. Thorud E, Clausen OPF, Abyholm T. Fine needle aspiration biopsies from human testis evaluated by DNA flow cytometry. Acta Pathol. Microbiol. Scand. (Suppl.) Series A-Flow cytometry IV. 1980:175-7.
31. 31. Toppari J, Vihko KK, Rasanen KGE, Eerola E, Parvinen M. Regulation of stages VI and VIII of rat seminiferous epithelial cycle in vitro. J Endocrinol. 1986;108:417-22.
32. 32. Aravindan GR, Ravindranath N, Gopalkrishnan K, Moudgal NR. DNA flow cytometry analysis of testicular germ cell population of the bonnet monkey (Macaca radiata) as a function of sexual maturity. J Reprod Fertil. 1990;89:397-406.
33. 33. Zante J, Schumann J, Göhde W, Hacker U. DNA fluorimetry of mammalian sperm. Histochemistry. 1977;54:1-7.
34. 34. Bianchi M. Testis, cytotoxic insult to tissue. In: Potten CS, Hendry JF, eds. Cytotoxic insult to germinal tissue: Part I. Edinburgh: Churchill Livingstone; 1983:259-307.
35. 35. Evenson DP, Baer RK, Jost LK, Gesch RW. Toxicity of thiotepa on mouse spermatogenesis as determined by dual-parameter flow cytometry. Toxicol Appl Pharmacol. 1986;82:151-63.
36. 36. Hacker-Klom U, Meistrich ML, Göhde W. Effect of doxorubicin and 4′-epidoxorubicin on mouse spermatogenesis. Mutat Res. 1986;160:39-46.
37. 37. Oakberg EF. Initial depletion and subsequent recovery of spermatogonia of mouse after 20 r of gamma rays and 100, 300 and 600 r of x-rays. Radiation Res. 1959;11:700-19.
38. 38. Evenson DP, Jost LK. Hydroxyurea exposure alters mouse testicular kinetics and sperm chromatin structure. Cell Prolif. 1993;26: 147-59.